AcuPartD

Keeping you updated on the latest Medicare and Part D news

Medicare Part D Patients Bear The Cost Of ‘Me Too’ Brand-Name Drugs

Leave a comment

A 2016 study by Health Affairs has found that the prescribing of “me too” brand name drugs instead of the equivalent generic therapeutics is costing Medicare beneficiaries 10.5 times more in copays ($42 vs. $4).  These “me too” drugs are brand name drugs that come to market when there already is a generic therapeutic substitute on the market. As the patent for Prilosec was about to expire, Nexium came to market as a similar therapy, but has a slightly different chemical make-up. Manufacturers provide rebates to insurance companies to classify these drugs as “preferred” drugs on plan’s formularies. Preferred brand drugs usually have higher copays than generics do.

The two drugs studied, Nexium and Crestor, have generic therapeutic equivalents (omeprazole and atorvastatin, respectively) that are scientifically proven to be equally as effective as a treatment, thus classifying them as “me too” drugs. In 2013, prescribing omeprazole over Nexium would have saved $870 million dollars. The savings are even higher for prescribing atorvastatin over Crestor, with an estimated $1.208 billion in savings. Nexium and Crestor are significantly more expensive than their generic counterparts, despite each having one million less claims than the generic option.

The increasing burden of prescription drug costs on the Medicare program and its beneficiaries has many physician groups advocating for the prescribing of generic drugs over branded drugs when both drugs are similarly effective. Overall, the consensus is, “Don’t use expensive medications when an equally effective and lower-cost medication is available.”

Article

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s